- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01915966
Efficacy Study of a Ginger and Cardamom Gelatin for Xerostomy in Terminally Ill Patients
Randomized Clinical Trial of a Ginger and Cardamom Gelatin Compared to a Camomile and Lemon Juice Infusion in Control of Xerostomy in Terminally Ill Patients
Xerostomia or dry mouth is the subjective feeling that there is not enough saliva in your mouth. It's a frequent symptom in terminally ill patients receiving palliative care, reducing their quality of life and comfort. Usual recommendations in these patients are good oral hygiene and mouthwashes, ad libitum consumption of camomile and lemon juice infusions, and ad libitum sucking of cold (e.g. ice, ice cream) or citric products (e.g. pineapple). Other xerostomia treatments such as artificial saliva and pharmacological drugs (e.g. pilocarpine) are less used in terminally ill patients due to cost and secondary effects.
The purpose of this randomized parallel clinical trial is to determine if a new recipe of gelatin with orange juice, cardamome and ginger is more effective in the control of xerostomia than the usual treatment of camomile infusion with lemon juice against. Treatments will be consumed ad libitum during one week. The main outcome is the subjective assessment of dry mouth at end of treatment.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain
- MUTUAM
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years or older
- Receiving palliative care for terminall illness at MUTUAM PADES
- Complaining of dry mouth and should not have been treated for this problem
- Able to prepare the study supplemental products by himself/herself or having a personal carer willing to do so
Exclusion Criteria:
- Disease of oral mucosa (e.g. oral mycosis, coated oral cavity ).
- Oropharinx neoplasm treated with surgery or radiotherapy.
- Severe cognitive impairment (More than 7 errors in Pfeiffer scale)
- Motor dysphagia causing coordination problems in swallowing.
- Life expectancy less than seven days (Last Days Situation).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cardamom, ginger and orange juice gelatin
Dietary Supplement
|
Patients will receive the recipe of the gelatin, with detailed instructions to prepare it at home, and the necessary ingredients for the gelatin.
If necessary, they will be helped in the preparation of an initial batch that should last for one week of treatment.
Patients will be instructed to consume the gelatin candy as necessary to alleviate the dry mouth sensation
|
|
Active Comparator: Camomile infusion with lemon juice
Dietary Supplement
|
Patients will receive instructions to prepare the infusion at home, and the necessary ingredients.
Patients will be instructed to ingest the infusion as necessary to alleviate the dry mouth sensation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Scale of self-perceived mouth dryness (0=not at all, 10=very dry)
Time Frame: At end of treatment (1 week )
|
At end of treatment (1 week )
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objective signs of xerostomia
Time Frame: At end of treatment (1 week )
|
Investigator will assess the presence of xerostomia signs through the assessment of 1) appearance and degree of dryness of tongue, buccal mucosa and lips, and 2)difficulties in speech derived from dry-mouth sensation in the patient.
|
At end of treatment (1 week )
|
|
Scale of subjective assessment of salival disfunction (Pai 2001).
Time Frame: At end of treatment (1 week )
|
At end of treatment (1 week )
|
|
|
Treatment acceptability
Time Frame: At end of treatment (1 week )
|
Participants will answer an open-question regarding their satisfaction with the treatment received, with regards to taste, texture, difficulty of preparation, etc.
|
At end of treatment (1 week )
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Teresa Peris, RN, MUTUAM
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FICE-MUT-02-1933-2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mouth Diseases
-
Hama UniversityCompletedEdentulous MouthSyrian Arab Republic
-
Cairo UniversityUnknown
-
Ivoclar Vivadent AGActive, not recruiting
-
University of BernCompleted
-
Sudimplant SAS - Groupe TBRActive, not recruiting
-
October University for Modern Sciences and ArtsCompleted
-
Universidade Federal de GoiasCompletedEdentulous MouthBrazil
-
Universitat Internacional de CatalunyaRecruitingEdentulous MouthSpain
-
EuroteknikaEVAMEDRecruitingEdentulous MouthFrance
-
October University for Modern Sciences and ArtsCompleted
Clinical Trials on Cardamom, ginger and orange juice gelatin
-
PepsiCo Global R&DCompletedDigestive HealthUnited States
-
María-Teresa García-ConesaUniversidad Católica San Antonio de MurciaCompleted
-
PepsiCo Global R&DCompletedGlycemic ResponseUnited States
-
Loma Linda UniversityCompletedBlood PressureUnited States
-
University of ReadingCompleted
-
Quadram Institute BioscienceBiotechnology and Biological Sciences Research Council; European CommissionCompleted
-
Hasselt UniversityHochschule Geisenheim UniversityCompleted
-
TNOCompletedInflammation | Alcohol ConsumptionNetherlands
-
Rutgers, The State University of New JerseyCompleted
-
University of HohenheimCompleted